Jennifer Anaquod and her son, Jonathan, 8, hold up a picture of Shantee. Miranda Gathercole Langley Times

Jennifer Anaquod and her son, Jonathan, 8, hold up a picture of Shantee. Miranda Gathercole Langley Times

VIDEO: Langley mom pleads for help in securing $750,000 life-saving drug for daughter

UBC student Shantee Anaquod is in desperate need of Soliris to treat aHUS

At first, she thought it was the flu.

Two days after Thanksgiving, Shantee Anaquod, 23, was busy preparing for anthropology midterms at UBC when she started “feeling weird.”

By Thursday, she could no longer keep food or water down and took herself to the hospital, only to be sent home with some Gravol.

Her symptoms rapidly became worse, and on Sunday, Shantee knew if she didn’t make it to the hospital she was going to die. She called a cab to take her to emergency, and within two hours had lost her vision and ability to walk.

By the time her mom, Jennifer, got to Burnaby General Hospital from Langley that night, Shantee had already been given four pints of blood and two bags of plasma.

“Her body was starting to shut down non-vital functions … because she only had about a third of the blood she needed in her body,” Jennifer said.

Doctors initially thought Shantee had the rare blood disorder Thrombotic Thrombocytopenic Purpura (TTP), but soon changed the diagnosis to an even rarer, life-threatening condition, Atypical Hemolytic Uremic Syndrome (aHUS).

This disease — which affects only one in a million people, or between 100 and 150 Canadians — causes a protein to be built that attacks the body’s own healthy cells. This leads to many tiny blood clots being formed, which in turn shred the red blood cells as they go through the kidneys, causing the kidneys to shut down and red blood cell count to drop.

It is a genetic disease that can manifest in the body at any time and at any age, or in some people, not at all. Oftentimes, a traumatic event will trigger the mutated gene to begin producing the destructive protein.

Upon this diagnoses, Shantee was transferred to Vancouver General Hospital to begin plasma exchange, a treatment that removes damaged plasma from the blood and replaces it with donor plasma.

But doctors soon had to stop the treatment as Shantee had an extreme allergic reaction to the donor plasma that caused her to grow dozens of hives on top of each other — something the hospital had never seen, Jennifer said. It took five days for staff to get the right solution of plasma mixed with medication to stop the outbreaks.

Now, Shantee spends her days in extreme pain and a constant state of delirium, thanks to high dosages of steroids and Benadryl pumped into her jugular vein. Her kidneys have completely shut down, and she has recently contracted pneumonia as well from the fluid buildup in her lungs.

“She had headaches so bad she just couldn’t function,” Jennifer said. “She was begging at times, she just couldn’t go on. So they’ve worked really hard to try to get everything under control, but in order to get everything under control, she’s highly medicated. She’s on blood pressure medication every two hours. Without blood pressure medication her pressure sits at about 185/120. There’s been times where they’ve worried about her having a heart attack, having a stroke.”

But Shantee doesn’t have to be in pain.

There is one drug approved in Canada that treats patients with aHUS, and can many times return them to a regular life.

This drug — called Soliris — has been available in Canada since 2013, and it comes at a hefty price — $750,000 per year.

It is one of the most expensive drugs in the world, and neither Shantee’s extended medical plan, nor the B.C. government, provide coverage for it.

“I can’t wrap my head around that there’s a drug in Canada that costs $750,000,” Jennifer said.

“That’s the conversation that keeps playing through my head. The doctor came in and he said, ‘We think you have something called aHUS, do you have extended medical?’ Shantee said, ‘Yes.’ And he said, ‘They’ll probably say no, but, there’s a drug that can help you. But it’s expensive.’ We thought we’d do fundraisers or something.

“He said, ‘It’s $750,000 a year.’

“It was just like the world stopped.”

‘MIRACLE DRUG’

Some provinces do provide coverage for Soliris. Both Quebec and Ontario cover the full costs, while Alberta, Saskatchewan and Manitoba, provide partial funding on a case by case basis, said Margriet Eygenraam, director with aHUS Canada.

“If you ask me why the drug is so incredibly expensive, I would say it’s ridiculous, it’s over priced,” she said. “Having said that, rare disease drugs are, in general, almost always more expensive than a drug for a more common disease, just for the fact that there are not that many patients that have the disease. So if the manufacturer is doing all the research and is bringing a drug on the market, which is only used for patients that have an ultra rare disease, automatically the drug will always be more expensive.”

Before Soliris was available, plasma infusions and exchanges were generally the only treatments that were being used for aHUS. However, they do not cure the disease.

“It was something that could be used to at least try to save the patient’s life … It might save somebody from death, but there is a still a lot of major organ damage that is still being done to the body regardless of multiple plasma treatments,” Eygenraam said.

Soliris, by contrast, has the ability to stop the destructive activity altogether by blocking the part of the complement system that goes out of control.

“It has been hailed by experts in the world as a breakthrough treatment for this particular disease, aHUS. The sooner you can get on this drug, the better chances of survival and return to the complete health that you had,” Eygenraam said. “This drug is a miracle drug, it is a breakthrough treatment that has made a huge difference in patient’s lives.”

Part of the reason why Soliris is not covered is because when Health Canada approved the drug, it was not recommended for funding by the Canadian Health Technology Assessment, Eygenraam said. That means it is up to each individual province to decide.

“There is a drug that is readily available, but is not accessible because the B.C. government is refusing to fund the drug, and I find that so incredibly maddening and beyond unjustified and unethical,” Eygenraam said.

“To let somebody suffer, so badly, when they know there is a drug that could change her life completely, get her out of the hospital — probably within a week or two — and restore her kidney function and restore her back to the 23 year old healthy girl that she was less than a month ago. I find it completely beyond — I don’t even have words for it. I’m so upset, and we as a patient organization, we will do as much as we can.”

The B.C. Ministry of Health says it cannot cover the cost of Soliris at this time due to “unclear clinical benefit” and “high treatment costs.”

“When considering PharmaCare coverage for any drug, B.C.’s drug review process relies on the findings made by independent experts from the national Common Drug Review and B.C.’s Drug Benefit Council. These arms’ length bodies have recommended that public drug plans do not cover Soliris for aHUS due to unclear clinical benefit and high treatment costs set by the manufacturer Alexion. As a result, PharmaCare does not fund Soliris as a treatment for aHUS,” said Laura Heinze, manager of media relations and issues for the Ministry of Health.

“The Patent Medicine Price Review Board — Canada’s drug price watchdog — has also found that the price Alexion Pharma set for its drug Soliris, is excessive.”

#FIGHTFORSHANTEE

For now, Shantee will continue to spend her days hooked to machines in hospital, doing plasma exchange for three hours every day and dialysis for four hours every second day.

“One of the doctors said this is the worst case they have ever seen of aHUS. She’s really slow to respond and will take two steps forward and three steps back. Like, her platelets were up, but then her hemoglobin dropped again,” Jennifer said.

“She’s been rushed for so many MRIs, so many CAT Scans, so many different things that’s it’s just terrifying. And she’s now starting to talk about things like, ‘I’ve had an interesting life, I guess,’ kind of that end of life. Being aware that without Soliris, there is a very good chance she won’t survive.

“In the literature they call it a catastrophic event, so ending with a heart attack or an aneurysm or a stroke because of the proteins in the blood. And the percentages are high.”

Jennifer has started the Facebook Page “Help Shantee fight for Soliris” and a GoFundMe fundraiser to help Shantee while she is in hospital and cannot work. Her goal is to raise $100,000 to help cover things like rent, or eventually at-home care, as she assumed they would never be able to raise enough money for the Soliris.

On Sunday (Nov. 5), a small group held a march outside of Vancouver General Hospital as well, carrying a sign that read “#FightForShantee.”

“I try to wrap my head around what I was doing at 23, and what she must feel like being told that her life as she planned it is over,” Jennifer said. “Those plans that you have for getting married, having children, travelling, all those things for her are gone.

“We’ll keep fighting in the hopes that there’s enough attention.”

To find out more, visit www.gofundme.com/mnqqhj-fight-for-shantee.

 

Jennifer Anaquod and her son, Jonathan, 8, hold up a picture of Shantee. Miranda Gathercole Langley Times

Jennifer Anaquod and her son, Jonathan, 8, hold up a picture of Shantee. Miranda Gathercole Langley Times

Shantee Anaquod. Submitted photo.

Shantee Anaquod. Submitted photo.

Shantee Anaquod and her brother, Jonathan. Submitted photo

Shantee Anaquod and her brother, Jonathan. Submitted photo

Shantee Anaquod. Submitted photo

Shantee Anaquod. Submitted photo

Just Posted

Raeya Evie Duncan was the 100th baby born at Chilliwack General Hospital for the month of May. She is seen here with her parents Alysha Williams and Andrew Duncan on June 12, 2021. (Jenna Hauck/ Chilliwack Progress)
Baby boom in Chilliwack as record number of infants born at CGH in May

‘COVID babies are coming out,’ says dad of 100th baby born at Chilliwack General Hospital last month

Syringes prepared with Pfizer’s COVID-19 vaccine at a vaccination site in Long Beach, Calif., Friday, March 5, 2021. (AP Photo/Jae C. Hong)
Walk-ins welcome at upcoming G.W. Secondary vaccine clinic

Second consecutive Saturday Fraser Health has scheduled a same-day clinic in a Chilliwack school

Migrating sockeye in the Fraser River August 7, 2007. (Fisheries and Oceans Canada)
First Nations, commercial, and recreational harvesters join forces to save Fraser River fish

‘We have to work together to rebuild these stocks while there is still time,’ says delegate

Vancouver courthouse. (Photo: Tom Zytaruk)
Man loses bid to appeal conviction for 1999 rape at Abbotsford music festival

James Redden, 53, formerly of Nanaimo, was found guilty in 2019 following six-day trial

Dozens of demonstrators gathered in March at the Hope Station House, showing support for preserving the 1916 building. (Photo/Christian Ward)
New reports breathe life into efforts to save the Hope Station House

The documents were presented to District of Hope Council at a meeting June 14

People watch a car burn during a riot following game 7 of the NHL Stanley Cup final in downtown Vancouver, B.C., in this June 15, 2011 photo. THE CANADIAN PRESS/Geoff Howe
10 years ago: Where were you during the 2011 Vancouver Stanley Cup Riots?

Smashed-in storefronts, looting, garbage can fires and overturned cars some of the damage remembered today

(Black Press Media file)
Dirty money: Canadian currency the most germ-filled in the world, survey suggests

Canadian plastic currency was found to contain 209 bacterial cultures

(pixabay file shot)
B.C. ombudsperson labels youth confinement in jail ‘unsafe,’ calls for changes

Review states a maximum of 22 hours for youth, aged 12 from to 17, to be placed in solitary

Cannabis bought in British Columbia (Ashley Wadhwani/Black Press Media)
Is it time to start thinking about greener ways to package cannabis?

Packaging suppliers are still figuring eco-friendly and affordable packaging options that fit the mandates of Cannabis Regulations

Eleonore Alamillo-Laberge, 6, reads a book in Ottawa on Monday, June 12, 2017. THE CANADIAN PRESS/Sean Kilpatrick
Parents will need to fight ‘COVID learning slump’ over summer: B.C. literacy experts

Parents who play an active role in educating their children this summer can reverse the slump by nearly 80%, says Janet Mort

The border crossing on Highway 11 in Abbotsford heading south (file)
Western premiers call for clarity, timelines on international travel, reopening rules

Trudeau has called Thursday meeting, premiers say they expect to leave that meeting with a plan

The B.C. government’s vaccine booking website is busy processing second-dose appointments, with more than 76 per cent of adults having received a first dose. THE CANADIAN PRESS/Jonathan Hayward
B.C.’s COVID-19 infections, hospitalizations stable for Tuesday

108 new confirmed cases, 139 in hospital, 39 in intensive care

A worker, at left, tends to a customer at a cosmetics shop amid the COVID-19 pandemic Thursday, May 20, 2021, in Los Angeles. (AP Photo/Marcio Jose Sanchez)
Half of cosmetics sold in Canada, U.S. contain toxic chemicals: study

Researchers found that 56% of foundations and eye products contain high levels of fluorine

Most Read